[go: up one dir, main page]

WO1997004750A3 - Procede de preparation de formes galeniques solides de medicaments en tres faibles doses - Google Patents

Procede de preparation de formes galeniques solides de medicaments en tres faibles doses Download PDF

Info

Publication number
WO1997004750A3
WO1997004750A3 PCT/EP1996/003326 EP9603326W WO9704750A3 WO 1997004750 A3 WO1997004750 A3 WO 1997004750A3 EP 9603326 W EP9603326 W EP 9603326W WO 9704750 A3 WO9704750 A3 WO 9704750A3
Authority
WO
WIPO (PCT)
Prior art keywords
low
dosage forms
solid dosage
preparing solid
dose drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP1996/003326
Other languages
English (en)
Other versions
WO1997004750A2 (fr
Inventor
James Albert Napper
Neil Mortimer
Karen Triona O'brien
Sultan James Manek
Rajinder Kumar
Michael Sidney George Clark
Julia Mary Loudon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9515624.6A external-priority patent/GB9515624D0/en
Priority claimed from GBGB9606684.0A external-priority patent/GB9606684D0/en
Priority to JP9507243A priority Critical patent/JPH11510493A/ja
Priority to APAP/P/1998/001170A priority patent/AP858A/en
Priority to EP96927621A priority patent/EP0841902A2/fr
Priority to EA199901055A priority patent/EA199901055A1/ru
Priority to AU67384/96A priority patent/AU716961B2/en
Priority to MX9800809A priority patent/MX9800809A/es
Priority to BR9609804A priority patent/BR9609804A/pt
Priority to IL12289796A priority patent/IL122897A0/xx
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to IL14957996A priority patent/IL149579A0/xx
Priority to EA199800179A priority patent/EA000740B1/ru
Priority to NZ315632A priority patent/NZ315632A/xx
Priority to SK110-98A priority patent/SK11098A3/sk
Publication of WO1997004750A2 publication Critical patent/WO1997004750A2/fr
Publication of WO1997004750A3 publication Critical patent/WO1997004750A3/fr
Priority to NO980384A priority patent/NO980384L/no
Anticipated expiration legal-status Critical
Priority to BG102266A priority patent/BG102266A/xx
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Cette invention concerne un procédé de formulation d'un médicament qui consiste à mélanger des particules d'excipient à une solution aqueuse contenant un médicament, ladite solution représentant de 1 à 3 % en poids du mélange total. L'invention concerne également un procédé de traitement et/ou de prophylaxie de la démence qui consiste à administrer à un patient du monochlorhydrate de [R-(Z)]-α-(méthoxyimino)-α-(1-azabicyclo[2.2.2]oct-3-yl)acétonitrile en une dose quotidienne ne dépassant pas 0,01mg/kg, ainsi que les compositions pharmaceutiques utilisées dans ce type de traitement.
PCT/EP1996/003326 1995-07-29 1996-07-29 Procede de preparation de formes galeniques solides de medicaments en tres faibles doses Ceased WO1997004750A2 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
NZ315632A NZ315632A (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
SK110-98A SK11098A3 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs
IL14957996A IL149579A0 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of low-dose drugs
EP96927621A EP0841902A2 (fr) 1995-07-29 1996-07-29 Procede de preparation de formes galeniques solides de medicaments en tres faibles doses
EA199901055A EA199901055A1 (ru) 1995-07-29 1996-07-29 Фармацевтическая композиция для лечения и/или профилактики деменции
AU67384/96A AU716961B2 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs
MX9800809A MX9800809A (es) 1995-07-29 1996-07-29 Procedimiento para preparar formas de dosis solidas de dosis muy bajas del farmaco.
BR9609804A BR9609804A (pt) 1995-07-29 1996-07-29 Processo para a preparação de formas farmacéuticas sólidas com drogas de dosagens muíto baixas
IL12289796A IL122897A0 (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs
JP9507243A JPH11510493A (ja) 1995-07-29 1996-07-29 非常に低用量の薬剤の固形剤形の製造方法
APAP/P/1998/001170A AP858A (en) 1995-07-29 1996-07-29 Process for preparing solid dosage forms of very low-dose drugs.
EA199800179A EA000740B1 (ru) 1995-07-29 1996-07-29 Способ получения твердого терапевтически активного лекарственного средства, содержащего лекарство в малых дозах, и лекарственное средство, полученное этим способом
NO980384A NO980384L (no) 1995-07-29 1998-01-28 Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
BG102266A BG102266A (en) 1995-07-29 1998-02-20 Method for the preparation of solid batched forms having very low doses of the medicamentous form

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9515624.6A GB9515624D0 (en) 1995-07-29 1995-07-29 Novel process
GB9515624.6 1995-07-29
GB9606684.0 1996-03-29
GBGB9606684.0A GB9606684D0 (en) 1996-03-29 1996-03-29 Novel process

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09000252 A-371-Of-International 1998-07-08
US09/759,575 Continuation US20010018074A1 (en) 1995-07-29 2001-01-12 Process for preparing solid dosage forms of very low-dose drugs

Publications (2)

Publication Number Publication Date
WO1997004750A2 WO1997004750A2 (fr) 1997-02-13
WO1997004750A3 true WO1997004750A3 (fr) 1997-03-27

Family

ID=26307485

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1996/003326 Ceased WO1997004750A2 (fr) 1995-07-29 1996-07-29 Procede de preparation de formes galeniques solides de medicaments en tres faibles doses

Country Status (25)

Country Link
EP (1) EP0841902A2 (fr)
JP (1) JPH11510493A (fr)
KR (1) KR19990035972A (fr)
CN (1) CN1196677A (fr)
AP (1) AP858A (fr)
AR (1) AR004178A1 (fr)
AU (1) AU716961B2 (fr)
BG (1) BG102266A (fr)
BR (1) BR9609804A (fr)
CA (1) CA2228048A1 (fr)
CZ (1) CZ24798A3 (fr)
DZ (1) DZ2077A1 (fr)
EA (2) EA000740B1 (fr)
HU (1) HUP9900521A3 (fr)
IL (1) IL122897A0 (fr)
MA (1) MA23953A1 (fr)
MX (1) MX9800809A (fr)
NO (1) NO980384L (fr)
NZ (1) NZ315632A (fr)
OA (1) OA10659A (fr)
PL (1) PL325242A1 (fr)
SK (1) SK11098A3 (fr)
TR (1) TR199800156T1 (fr)
UY (1) UY24297A1 (fr)
WO (1) WO1997004750A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9619074D0 (en) * 1996-09-12 1996-10-23 Smithkline Beecham Plc Composition
TR200002626T2 (tr) 1998-03-11 2001-03-21 Smithkline Beecham Plc Terkip
FR2796840B1 (fr) * 1999-07-26 2003-06-20 Ethypharm Lab Prod Ethiques Comprimes faiblement doses et procede de preparation
ES2253451T3 (es) 2000-12-14 2006-06-01 Ortho-Mcneil Pharmaceutical, Inc. Productos a base de hormona esteroide y sus procedimientos de fabricacion.
JP2007532511A (ja) * 2004-04-09 2007-11-15 スミスクライン ビーチャム コーポレーション 低用量医薬品

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
EP0392803A1 (fr) * 1989-04-13 1990-10-17 Beecham Group p.l.c. Composés chimiques
WO1995017168A1 (fr) * 1993-12-21 1995-06-29 Applied Analytical Industries, Inc. Procede de preparation de produits pharmaceutiques a faible dosage

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
JPS5970614A (ja) * 1982-10-14 1984-04-21 Asahi Chem Ind Co Ltd 微量主薬系湿式固形製剤方法
US4898736A (en) * 1988-03-09 1990-02-06 Merck & Co., Inc. Method for tablet preparation
EP0392803A1 (fr) * 1989-04-13 1990-10-17 Beecham Group p.l.c. Composés chimiques
WO1995017168A1 (fr) * 1993-12-21 1995-06-29 Applied Analytical Industries, Inc. Procede de preparation de produits pharmaceutiques a faible dosage

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 101, no. 8, 20 August 1984, Columbus, Ohio, US; abstract no. 60165, XP002024576 *

Also Published As

Publication number Publication date
HUP9900521A3 (en) 2001-04-28
CZ24798A3 (cs) 1998-06-17
UY24297A1 (es) 1997-01-23
BR9609804A (pt) 1999-07-06
AP858A (en) 2000-07-12
EA000740B1 (ru) 2000-02-28
NO980384L (no) 1998-03-26
EP0841902A2 (fr) 1998-05-20
BG102266A (en) 1998-10-30
AR004178A1 (es) 1998-11-04
AU6738496A (en) 1997-02-26
MA23953A1 (fr) 1997-04-01
IL122897A0 (en) 1998-08-16
CA2228048A1 (fr) 1997-02-13
TR199800156T1 (xx) 1998-04-21
PL325242A1 (en) 1998-07-06
AP9801170A0 (en) 1998-01-31
HUP9900521A2 (hu) 1999-06-28
EA199901055A1 (ru) 2000-06-26
JPH11510493A (ja) 1999-09-14
SK11098A3 (en) 1998-07-08
DZ2077A1 (fr) 2002-07-22
OA10659A (en) 2002-09-18
CN1196677A (zh) 1998-10-21
NZ315632A (en) 1999-11-29
EA199800179A1 (ru) 1998-10-29
NO980384D0 (no) 1998-01-28
WO1997004750A2 (fr) 1997-02-13
AU716961B2 (en) 2000-03-09
MX9800809A (es) 1998-04-30
KR19990035972A (ko) 1999-05-25

Similar Documents

Publication Publication Date Title
EP1243267A3 (fr) Composition pharmaceutique contenant de l'amoxicilline et du clavulanate
NZ508526A (en) Opioid formulations for treating pain
IL114596A (en) Pharmaceutical compositions containing an active substance blended with a carrier process for preparation thereof and their use for preparation of inhalated drugs
MY125662A (en) Pharmaceutical formulations containing darifenacin
CA2114014A1 (fr) Systeme d'administration de medicament et methode pour traiter a l'aide de la carbamazepine les troubles psychiatriques, neurologiques et autres
EP1003373A4 (fr) Compositions et methodes permettant d'attenuer la depression respiratoire et les effets secondaires des composes opioides mu
ZA876731B (en) Therapeutic agents
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
RO116343B1 (ro) Compoziţie farmaceutică şi metodă de tratament a infecţiilor bacteriene la pacienţi pediatrici
GR3020098T3 (en) 11-Beta-aryl-4-estrene, method for its production and its use as a medicine
RU96123126A (ru) Агенты для лучевой терапии, содержащие олово-117m
Cefali et al. Pharmacokinetic study of zeolite A, sodium aluminosilicate, magnesium silicate, and aluminum hydroxide in dogs
AU703311B2 (en) Composition containing diosgenin
PL339774A1 (en) Method of preventing nephrotoxicity caused by cephalosporins and tacrolimus
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
WO1997004750A3 (fr) Procede de preparation de formes galeniques solides de medicaments en tres faibles doses
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
CZ20014190A3 (cs) Terapeutické pouľití melatoninu
CA2078869A1 (fr) Compositions pharmaceutiques contenant de l'ipriflavone, leur procede de preparation et leur emploi therapeutique relatif
ES2184561A1 (es) Forma farmaceutica solida de administracion oral dispersable en agua para el tratamiento de la tuberculosis conteniendo refampicina, isoniazida, pirazinamida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
ES2179729A1 (es) Forma farmaceutica solida de administracion oral dispersable en agua, que comprende rifampicina, isoniazida y piridoxina hidrocloruro, procedimiento para su obtencion y forma de presentacion de dicha forma farmaceutica.
UA66925C2 (uk) Поліморфні форми кристалічного цитрату азабіцикло[2.2.2]-октан-3-аміну, спосіб їх одержання, фармацевтична композиція та спосіб лікування блювання
CA2018227C (fr) Association de vitamine a en dose physiologique et de divers principes actifs ayant des proprietes therapeutiques
GB2336999A (en) High-dosage triclosan compositions
RU99112967A (ru) Способ лечения и профилактики дизентерии свиней

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 96197054.5

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 315632

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 1199800050

Country of ref document: VN

WWE Wipo information: entry into national phase

Ref document number: 1996927621

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1019980700633

Country of ref document: KR

Ref document number: 98-00115

Country of ref document: RO

WWE Wipo information: entry into national phase

Ref document number: 11098

Country of ref document: SK

Ref document number: PV1998-247

Country of ref document: CZ

ENP Entry into the national phase

Ref document number: 2228048

Country of ref document: CA

Ref document number: 2228048

Country of ref document: CA

Kind code of ref document: A

Ref document number: 1997 507243

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: PA/a/1998/000809

Country of ref document: MX

Ref document number: 1998/00156

Country of ref document: TR

WWE Wipo information: entry into national phase

Ref document number: 199800179

Country of ref document: EA

WWP Wipo information: published in national office

Ref document number: 1996927621

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: PV1998-247

Country of ref document: CZ

WWP Wipo information: published in national office

Ref document number: 1019980700633

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 149579

Country of ref document: IL

WWW Wipo information: withdrawn in national office

Ref document number: 1996927621

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: PV1998-247

Country of ref document: CZ

WWR Wipo information: refused in national office

Ref document number: 1019980700633

Country of ref document: KR